InvestorsHub Logo
Followers 57
Posts 5699
Boards Moderated 0
Alias Born 12/13/2004

Re: falconer66a post# 172460

Monday, 11/19/2018 11:26:26 AM

Monday, November 19, 2018 11:26:26 AM

Post# of 460518
falconer...thanks for a very interesting and inspiring series of posts. I agree with your assessment of the science. However I do expect some share action to take place in 2019. I think Parkinson and Rett data will affect the share price, and I do expect early interim safety analysis of the Alzheimer trial could result in rapid approval in Australia. I think Drs. Hampel and MacFarlane would press a very willing Australian government to make available a drug which is far superior to the current SOC. Indeed there is crying need for something better than the current SOC in PD and Rett's...and advocacy groups ready to press for rapid approvals in both of those indications!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News